rvallee
Senior Member (Voting Rights)
They only looked at clinical trials and systematic reviews of clinical trials. Somehow labeled as randomized controlled trials even though almost none of them are. It's basically, what, the tier 2 Rituximab trial and maybe a handful about supplements? All the others are open label randomized trials with subjective outcomes. So that would be most of the biopsychosocial evidence base:I can't see that this has been shared. It is Swedish Agency for Health Technology Assessment and Assessment of Social Services (Statens beredning för medicinsk och social utvärdering, SBU) that have compiled the scientific basis on which the National Board of Health and Welfare bases its report.
”SBU has mapped what research is available on the effects of treatments and rehabilitation efforts in post-covid and other related conditions and syndromes: ME/CFS chronic fatigue syndrome, Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS), long-term problems after sepsis and influenza and in the condition Postural orthostatic tachycardia syndrome (POTS). The report describes the systematic reviews and primary studies that have been included.”
Via Google translate:
https://www-sbu-se.translate.goog/s...l=auto&_x_tr_tl=en&_x_tr_hl=sv&_x_tr_pto=wapp
Correct. It's so annoying how we can't do some of this basic academic work because if someone collected all those quotes from authoritative sources it would add up to a very damning picture. On the eminence game, the quacks have lost. Authoritative bodies have basically declared it all irrelevant.Overall, the state of knowledge is deficient for all the conditions investigated
But instead we live in the alternative reality where despite this, this deficient state of knowledge rules every damn thing about it and continues to suck up most of the public funding.
This also is very significant given that this basically describes all systematic reviews, including the awful Cochrane exercise review:
Although this is a bit odd, since if anything they are almost identical, but they have zero consistency with one another and any interpretation is down to preferences and biases. They all follow the same patterns, aims, but with the same general lack of coherence that makes them impossible to reliably compare. It's the very nature of pragmatic trials that is at fault. They are largely uninterpretable by nature.The included studies were very different and therefore we judged that it was not meaningful to make comparisons of reported efficacy results, or to assess the reliability of those results
Similar to what the NIH, IOM/NAM, CDC, NICE, IQWIG and others found, it's all garbage, not even worth looking at:
It's too long for me to read through but it looks technically sound. And devastating to the dominant biopsychosocial model whose proponents somehow pretend like they're the underdogs who were never given a chance. Not that I expect it will persuade anyone from continuing to fund studies that will inevitably be marked down as deficient despite being used to justify more failure. So far most LC studies have all the same flaws and biases.For the conditions ME/CFS, only two articles were included in addition to what was included in SBU's previous evaluation of the state of knowledge from 2019.
Last edited: